SEC Comment Letter 0000000000-24-007715 to Intra-Cellular Therapies, Inc. (ITCI) (CIK 0001567514)
Intra-Cellular Therapies, Inc. (ITCI) (CIK 0001567514)
Date: July 8, 2024 · CIK: 0001567514 · Accession: 0000000000-24-007715
AI Filing Summary & Sentiment
File numbers found in text: 001-36274
Letter
July 8, 2024 Lawrence J. Hineline Sr. VP of Finance, CFO Intra-Cellular Therapies, Inc. 30 East 29th Street New York , New York 10016 Re:Intra-Cellular Therapies, Inc. Form 10-K for the Fiscal Year Ended December 31, 2023 Filed February 22, 2024 File No. 001-36274 Dear Lawrence J. Hineline: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences
Show Raw Text
July 8, 2024
Lawrence J. Hineline
Sr. VP of Finance, CFO
Intra-Cellular Therapies, Inc.
30 East 29th Street
New York , New York 10016
Re:Intra-Cellular Therapies, Inc.
Form 10-K for the Fiscal Year Ended December 31, 2023
Filed February 22, 2024
File No. 001-36274
Dear Lawrence J. Hineline:
We have completed our review of your filing. We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Life Sciences